SCHEMBL822080

SCHEMBL822080

C=CCOC(F)=C(C(F)(F)F)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233481 0.75
SCHEMBL2819222 0.75
SCHEMBL8637003 0.74
SCHEMBL31732818 0.73 CYP3A4 (0.31) CYP3A4
SCHEMBL13351664 0.71 CYP3A4 (0.33) CYP3A4
SCHEMBL8419481 0.70
SCHEMBL13866368 0.70 CYP3A4 (0.32) CYP3A4
SCHEMBL4864146 0.70 CYP3A4 (0.32) CYP3A4
SCHEMBL4361874 0.70 CYP3A4 (0.32) CYP3A4
SCHEMBL1082749 0.70 CYP3A4 (0.41) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670294-B1 Process for making hexafluoropropane and perfluoropropane MINNESOTA MINING & MFG (US) 1999-09-22 EP claimed
EP-0753085-B1 PROCESS FOR PREPARING BRANCHED PERFLUOROCHEMICALS MINNESOTA MINING & MFG (US) 1999-09-08 EP claimed
EP-0753085-A1 PROCESS FOR PREPARING BRANCHED PERFLUOROCHEMICALS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-01-15 EP claimed
WO-1995026429-A1 PROCESS FOR PREPARING BRANCHED PERFLUOROCHEMICALS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-10-05 WO claimed
EP-0670294-A2 Process for making hexafluoropropane and perfluoropropane MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-06 EP claimed
US-5427656-A Process for preparing branched perfluorochemicals MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-06-27 US claimed
JP-61277645-A None JP disclosed
JP-61069745-A None JP disclosed
JP-60218356-A None JP disclosed
JP-7309791-A None JP disclosed
JP-63035539-A None JP disclosed
US-8067528-B2 Method for producing fluorine-containing polymer, aqueous dispersion of fluorine-containing polymer, 2-acyloxycarboxylic acid derivative, and surface active agent DAIKIN INDUSTRIES, LTD. (JP) 2011-11-29 US disclosed
US-20100234635-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER, AQUEOUS DISPERSION OF FLUORINE-CONTAINING POLYMER, 2-ACYLOXYCARBOXYLIC ACID DERIVATIVE, AND SURFACE ACTIVE AGENT DAIKIN INDUSTRIES, LTD. (JP) 2010-09-16 US disclosed
US-5427656-A Process for preparing branched perfluorochemicals MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-06-27 US disclosed
US-4960947-A Process for producing hexafluoroacetone or its hydrate NIPPON MEKTRON LIMITED (JP) 1990-10-02 US disclosed
US-4885398-A Process for producing hexafluoroacetone or its hydrate NIPPON MEKTRON LIMITED (JP) 1989-12-05 US disclosed
JP-S6335539-A PRODUCTION OF HEXAFLUOROISOBUTANOIC ACID NIPPON MEKTRON LTD 1988-02-16 JP disclosed
JP-S61277645-A PRODUCTION OF HEXAFLUOROACETONE NIPPON MEKTRON LTD 1986-12-08 JP disclosed
JP-S6169745-A PRODUCTION OF HEXAFLUOROISOBUTANOIC ACID ESTER NIPPON MEKTRON LTD 1986-04-10 JP disclosed
JP-S60218356-A PREPARATION OF 2,2-BISTRIFLUOROMETHYLALKANOYL FLUORIDE DAIKIN IND LTD 1985-11-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234635-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER, AQUEOUS DISPERSION OF FLUORINE-CONTAINING POLYMER, 2-ACYLOXYCARBOXYLIC ACID DERIVATIVE, AND SURFACE ACTIVE AGENT PFAS, F7, FGB CYP3A4 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.